Literature DB >> 29649889

Endoscopic Resection of Sinonasal Inverted Papilloma: Systematic Review and Meta-Analysis.

John K Goudakos1,2, Sarantis Blioskas2, Angelos Nikolaou3, Konstantinos Vlachtsis3, Peter Karkos4, Konstantinos D Markou2.   

Abstract

Background Pure endoscopic surgery (functional endoscopic sinus surgery) has been increasingly replacing external approaches in the management of sinonasal inverted papillomas. Objective To analyze and compare the effectiveness of pure endoscopic procedure with external or combined procedures to paranasal inverted papillomas, including the experience from two institutions in North Greece, over a 20-year period. Methods Systematic literature searches of MEDLINE (1952-2016), EMBASE (1974-2016), and the Cochrane Central Register of Controlled Trials. Review of all English-language studies comparing endoscopic and open techniques. Odds ratios (ORs), risk ratio, 95% confidence intervals (CIs), and tests for heterogeneity were reported. Recurrence rates according to initial tumor stage. Results In total, 2451 patients had been enrolled in the 23 studies, published between 1992 and 2014. All the included articles are graded as level IV evidence. Among the 1526 patients of the endoscopic group, 212 (13.8%) had recurrence, with the mean time of recurrence to range from 14 to 46.6 months. In the external approach group, 111 (18.7%) of the 592 patients had recurrence, with the time of recurrence to range from 7 to 92 months. The recurrence rate in the combined approach group was 12.9%. The occurrence rate of recurrence attributable to the surgical choice was significantly different between endoscopic and external group (OR: 0.61; 95% CI: 0.40-0.92; P = 0.02; 14.9% vs. 18.8% in endoscopic and external group, respectively). Conclusions The present systematic review and meta-analysis indicates that endoscopic approach seems a favorable treatment option of sinonasal inverted papillomas and confirms the global recommendation that is the gold standard in the treatment of such nose lesions, revealing a lower recurrence rate compared to external approaches.

Entities:  

Keywords:  Schneiderian; benign; endoscopic; functional endoscopic sinus surgery; inverted; inverting; nose; paranasal; sinonasal; papilloma

Mesh:

Year:  2018        PMID: 29649889     DOI: 10.1177/1945892418765004

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  6 in total

1.  Synchronous sinonasal and respiratory papilloma: could long-term positive pressure ventilation be the cause? A rare case report.

Authors:  Shivani Angelique Kumar; Connor O'Meara; Felik Paulus; Laura Wise; Thomas Havas
Journal:  J Surg Case Rep       Date:  2022-06-28

Review 2.  Sinonasal Inverted Papilloma and Squamous Cell Carcinoma: Contemporary Management and Patient Outcomes.

Authors:  Jacob G Eide; Kevin C Welch; Nithin D Adappa; James N Palmer; Charles C L Tong
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

3.  Sine Qua Non: Sinonasal Inverted Papilloma.

Authors:  Frederic C Jewett; Michael J Coulter; Brenda L Nelson
Journal:  Head Neck Pathol       Date:  2021-02-05

4.  Sinonasal inverted schneiderian papilloma presenting as a large intraoral lesion.

Authors:  Kumar Nilesh; Srijon Mukherji; Sujata R Kanetkar; Aaditee Vande
Journal:  BMJ Case Rep       Date:  2020-07-05

5.  Clinicopathologic Analysis of Sinonasal Inverted Papilloma, with Focus on Human Papillomavirus Infection Status.

Authors:  Munechika Tsumura; Seiichiro Makihara; Asami Nishikori; Yuka Gion; Toshiaki Morito; Shotaro Miyamoto; Tomoyuki Naito; Kensuke Uraguchi; Aiko Oka; Tomoyasu Tachibana; Yorihisa Orita; Shin Kariya; Mitsuhiro Okano; Mizuo Ando; Yasuharu Sato
Journal:  Diagnostics (Basel)       Date:  2022-02-10

6.  Comparison of MRI and CT in the Evaluation of Unilateral Maxillary Sinus Opacification.

Authors:  Elise Chua; Annakan V Navaratnam; Dominic St Leger; Vincent Lam; Samit Unadkat; Alexander Weller
Journal:  Radiol Res Pract       Date:  2021-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.